On May 9, 2024, Eli Lilly and Company announced that it held its annual general meeting of shareholders on May 6, 2024, and declared voting results. Accordingly, a shareholder proposal from Trinity Health, requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
865.8 USD | +0.09% | +3.99% | +48.53% |
Jun. 11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Jun. 11 | Sector Update: Health Care Stocks Decline Tuesday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.53% | 780B | |
+41.30% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+17.58% | 244B | |
-1.10% | 217B | |
+11.39% | 214B | |
+4.40% | 161B | |
-2.64% | 159B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Declaration of Voting Results by Eli Lilly and Company